Background: Chronic Obstructive Pulmonary Disease (COPD) is one of the most common chronic diseases all around the world. One of suggested risk factors for COPD is Gastroesophageal Reflux Disease (GERD). The aim of this study was investigation of the association between micro-aspiration of bile acid and pepsin with exacerbation attacks in COPD patients.
INTRODUCTION

World Health Organization (WHO) has defined
Chronic Obstructive Pulmonary Disease (COPD) as a collection of pulmonary diseases that cause irreversible airflow limitation and chronic bronchitis, and emphysema and small airway disease are included in this group (1) . In 2015, it was estimated that nearly three million deaths (5% of all deaths) in the world were attributed to COPD, and more than 90% of them occurred in low-and middleincome countries (2) and it was predicted that this disease will be the third leading cause of death in the world by
(1).
Tobacco use is the primary risk factor for COPD and exposure to indoor and outdoor polluted air, as well as occupational dust, are other factors that cause this disease (2). The most important cause of death from COPD is acute exacerbations (3) . Acute exacerbations occur in patients who have had COPD for long time and suddenly face an acute increase in one or more of the following symptoms:
"cough frequency and severity; dyspnea; and change in the The mechanisms that affect acute exacerbations in COPD are not understood until now. According to the researches, more than 50% of the cases are due to viral and bacterial respiratory infections, 10% are due to environmental pollutions, and more than 30% are of unknown etiology (3, 5) .
Gastroesophageal Reflux Disease (GERD) is one of the risk factors that was proposed for COPD exacerbations and also among patients with GERD, upper respiratory symptoms are frequent (4, 6) . It has been demonstrated that Gastroesophageal Reflux (GER) plays an important role in causing extra-esophageal symptoms, including chronic bronchitis, bronchiectasis, diffuse panbronchiolitis, recurrent pneumonia, chronic cough, hoarseness, and asthma (7, 8) . Although available evidence suggests a relationship between COPD and GERD, but there are a few findings that show the impact of GER on the COPD and respiratory diseases (9, 10) . Micro-aspiration of gastric contents and bronchospasm due to vagal nerve stimulation following exposure of esophageal mucous membrane with gastric acid reflux are two major factors that explain the association between GER and the onset of pulmonary disease and its manifestations (11) . A study showed a moderate relationship between sputum and exhaled breath condensate pepsin concentrations and it was suggested that exhaled breath condensate pepsin may be a useful noninvasive marker of pulmonary micro-aspiration, but it cannot be used for diagnosis of GERD (12).
Several studies have been done to investigate the effect of reflux on the increasing of COPD exacerbations (4, (13) (14) (15) (16) and a systematic review and meta-analysis showed GERD is a risk factor for COPD exacerbations (17) . In a study in Canada, the results showed that in patients who developed obstructive bronchiolitis following lung transplantation, the prevalence of bile acid micro-aspiration is increased (15) . Meanwhile, in another study the authors showed 37%
of COPD patients had GER, and the number of COPD exacerbations in patients with GERD was reported two times more than GERD-free patients (2.3 compared to 1.6 in a year) (16) .
Regarding the prevalence of GERD in patients with COPD, the aim of this study was to investigate the association of bile acid and pepsin micro-aspiration with COPD exacerbations in Kerman.
MATERIALS AND METHODS
This was an analytical descriptive cross-sectional study.
According to previous studies, the sample size was 52
patients. Participants were patients with COPD and their disease was confirmed by a pulmonary specialist; they were selected by simple sampling from patients referring 
RESULTS
The mean age in groups of with and without COPD exacerbations history was 60.88±8.10 and 60.15±9.53 years, respectively. The large number (39 patients) (75%) of patients were male and without COPD exacerbation history (21 male patients in the past year). The BMI in groups of with and without COPD exacerbations history was 22.92±5.22 and 23.44±7.20, respectively and the number of participant who smoked was higher in the group that experienced at least one COPD exacerbation in the past year which was not significant either (P=0.50).
12 patients (46.2%) suffered from hoarseness in the first group (without COPD exacerbation) and 11 (42.3%) suffered from regurgitation in the second group (with COPD exacerbation) and these differences were not significant (P>0.05). The FEV1 based on the GOLD criteria showed that in both the first and the second groups with at least one COPD exacerbation during the past year, 13 of patients had moderate obstruction, and this was not statistically significant (P=0.964) (Table1). There was no correlation between micro-aspiration markers with clinical symptoms, FEV1 and BODE index (Table3). 
DISCUSSION
It has been shown that GERD and micro-aspiration are common in many chronic respiratory diseases including COPD (19) . In all studies, micro-aspiration of bile acid and pepsin was seen (the mean was 29.84±4.30 µmol/Lit) but we did not find any association between amount of microaspiration and number of COPD exacerbations. In the present study, although the mean of bile acid and pepsin in the BALF of group without COPD exacerbation was lower than the group with COPD exacerbation, these differences were not significant and so, there was no significant relationship between GERD 
CONCLUSION
According to the results of this study, there was not any association between micro-aspiration of bile acid and pepsin with COPD exacerbations, severity of COPD, BODE-index and GERD symptoms.
